FDA panel backs Gardasil (HPV vaccine) safety and efficacy for genital warts in young men

Cancer, Children's Health, Men's Health, Parenting
News outlets are reporting that an FDA advisory panel "endorsed the use of" Merck's Gardasil "for boys and young men." The panel "voted in favor of the safety and efficacy of" the vaccine "to inhibit genital warts in boys and men ages nine to 26," the New York Times noted. The vaccine is already "approved ... to protect girls and women ages nine to 26 against certain strains of" human papillomavirus (HPV). (more…)
Read More